期刊文献+

全血γ-干扰素释放试验对活动性结核病的辅助诊断价值 被引量:5

Values of Whole Blood Interferon-γ Release Test in Active Tuberculosis's Auxiliary Diagnosis
下载PDF
导出
摘要 目的研究全血γ-干扰素(interferon gamma,IFN-γ)释放试验对活动性结核病的辅助诊断价值。方法应用化学发光酶免疫分析法分别检测124例结核病患者、60例非结核肺部疾病患者、33名健康对照者全血中IFN-γ水平;绘制受试者工作特征曲线(receiver operating characteristic curve,ROC曲线)确定其诊断活动性结核病的临界值,并评价其对活动性结核病的诊断效能。结果活动性结核病患者组结核特异性IFN-γ的水平为405±306pg/mL,显著高于非结核肺部疾病组(111±127pg/mL,P<0.001)和健康对照组(52.20±28.28pg/mL,P<0.001)。而健康对照组与非结核肺部疾病组差异无统计学意义(P>0.05)。结核特异性IFN-γ诊断结核病的临界值为143pg/mL,其灵敏度和特异性分别为86.3%和77.8%。结论全血γ-干扰素释放试验可能成为活动性结核病辅助诊断指标之一。 Objective To explore the value of interferon-γ(IFN-γ)release test in active tuberculosis's auxiliary diagnosis Methods The whole blood levels of IFN-γ in 124 cases of tuberculosis patients,60 patients with non-tuberculous pulmonary diseases and 33 healthy controls were detected by Chemiluminescence enzyme immunoassay method.The receiver operating characteristic curve was drawn to determine the threshold of IFN-γ for diagnosis of active tuberculosis and to evaluate its diagnostic performance.Results The specific IFN-γ level in active tuberculosis group(405 ± 306 pg/mL) was significantly higher than that of non-tuberculous pulmonary disease group(111±127 pg/mL,P0.001) and healthy control group(52.20±28.28 pg/mL,P0.001),but the healthy control group and non-tuberculous respiratory disease group had no statistically significant difference(P0.05).The threshold of IFN-γ for diagnosis of tuberculosis was 143pg/mL and its sensitivity and specificity were 86.3% and 77.8% respectively.Conclusion The whole blood interferon-γ release test may be regarded as one of index in auxiliary diagnosis of active tuberculosis.
出处 《标记免疫分析与临床》 CAS 2012年第4期193-197,共5页 Labeled Immunoassays and Clinical Medicine
关键词 结核 Γ-干扰素 诊断 Tuberculosis Interferon-γ Diagnosis
  • 相关文献

参考文献12

  • 1World Health Organization. Global tuberculosis control: a short up- date to the 2009 report [ R ]. Geneva: World Health Or~r~nizAtion 2tq09 _.
  • 2Townsend P A, Cutress R I, Shar P A, et al. BAG- 1 : a multifunc- tional regulator of cell growth and survival [ J ]. Biochim Biophys Acta, 2003, 1603(2) : 83-98.
  • 3Mazurek G H, Jereb J. Guidehnes for using the Quanti FERON-TB gold test for detecting Mycobacterium tuberculosis infection [ J ]. United States MMWR Recomm, 2005, 54(15) : 49-55.
  • 4侯英,吴雪琼.化学发光酶免疫分析检测全血1-干扰素诊断结核杆菌感染方法的建立及应用[D].山西大学,2010.
  • 5结核病的诊断标准和分类(续完)[J].中国防痨杂志,1992,14(1):45-47. 被引量:1
  • 6结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 7Kaufmann S H. How can immunology contribute to the control of tu- berculosis? [ J ]. Nature Reviews Immunology, 2001, 1 ( 1 ) :20-30.
  • 8Ravn P, Munk M E, Andersen A B, et al. Prospective evaluation of a whole-blood test using mycobacterium tuberculosis-specific an- tigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis[ J]. Clin Diagn Lab Immunol, 2005, 12(4) : 491-496.
  • 9Tsiouris S J, Coetzee D, Toro P L, et al. Sensitivity analysis and potential uses of novel gamma interferon release assay for diagnosis of tuberculosis [ J ], J Clin Microbiol, 2006, 44 ( $ ) : 2544-2850.
  • 10Karam F, Mbow F, Fletcher H, et al. Sensitivity of IFN-gamma re- lease assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS [ J ]. PLoS One, 2008, 3(1) : e1441.

共引文献798

同被引文献41

  • 1Simithy T, Reeve N, Hobrath JV, et al. Identification of shikimate kinase inhibitors among anti-mycobacterium tuberculosis compounds by LC-MS [J]. Tuberculosis, 2014, 94 (2) : 152-158.
  • 2Kardos M, Kimball AB. Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting [J]. J Am AcadDermatol, 2012, 66 (1) : 148-152.
  • 3Ojo BA, Ogwuche EI, Duduyemi BM, et al. Testicular tuberculosis in an HIV positive patient mimicking malignancy: a case report [J]. African Journal of Urology, 2014, 20 (1) : 28-30.
  • 4Ruhwald M,Aabye MG,Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions[J]. Expert Rev Mol Diagn, 2012,12 (2) : 175-187.
  • 5Mazurek GH,Jereb J,Lobue P,et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacte- rium tuberculosis infection, United States [J]. MMWR Reeomm Rep,2005,54(RR-15) :49-55.
  • 6Syed Ahamed Kabeer B, Raman B,Thomas A, et al. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis[J]. PLoS One, 2010,5 (2) : e9051.
  • 7Wang S,Diao N, Lu C, et al. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagno- sis of active and latent tuberculosis in a BCG-vaccinated population[J]. PLoS One,2012,7(12) : e51338.
  • 8Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy[J]. Chest, 2007,131(6) :1898-1906.
  • 9Borgstrm E, Andersen P, Atterfelt F, et al. Immune re- sponses to ESAT-6 and CFP-10 by FASCIA and multi- plex technology for diagnosis of M. tuberculosis infec- tion: IP-10 is a promising marker[J].PLoS 0ne,2012,7 (11) : e43438.
  • 10Frahm M, Goswami ND, Owzar K, et al. Discriminating between latent and active tuberculosis with multiple bio- marker responses [J]. Tuberculosis, 2011, 91 (3): 250- 256.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部